Investment
Features
FeesSafety
Academy
More
Pluang+

Trump calls stock buybacks fake; MicroStrategy boosts value by issuing shares to buy Bitcoin.

Market News
22 Jun 2026
BeInCrypto
View Source
Neutral
pluang ai news

President Trump criticized stock buybacks as a fake method to raise share prices, urging companies to invest in capacity instead. In contrast, MicroStrategy uses a unique strategy by issuing new shares and preferred stock to buy Bitcoin, building a large crypto treasury. This approach lifts valuations only if investors pay a premium over the Bitcoin holdings' value. The company's stock value depends on Bitcoin's price rising above its purchase cost to sustain this premium and support further growth.

More News

Direct Bitcoin sales in Austria trigger a 27.5% tax on gains, same as exchange sales, with no automatic withholding.

Direct Bitcoin sales in Austria trigger a 27.5% tax on gains, same as exchange sales, with no automatic withholding.

In Austria, selling Bitcoin directly between private individuals is taxed the same as sales via crypto exchanges. The taxable event is the capital gain—the difference between sale proceeds and acquisition cost—with a 27.5% tax rate for Bitcoin acquir...

Market News
Neutral
4 hours ago
SEC approves Evernorth's $1B Nasdaq listing under XRPN despite XRP market slump

SEC approves Evernorth's $1B Nasdaq listing under XRPN despite XRP market slump

The U.S. SEC has approved Evernorth's registration, clearing the way for its $1 billion Nasdaq listing under the ticker XRPN through a merger with Armada Acquisition Corp. II. Evernorth plans to actively manage its XRP treasury to generate yield and ...

Market News
Bullish
4 hours ago
Amprius Technologies posts 125.7% revenue growth, raises 2026 guidance amid rising drone battery demand

Amprius Technologies posts 125.7% revenue growth, raises 2026 guidance amid rising drone battery demand

Amprius Technologies is benefiting from strong demand for drone batteries, reporting a 125.7% year-over-year revenue increase and improved gross margins. The company raised its 2026 revenue forecast to at least $140 million and aims for $600 million ...

Analyst Insights
Bullish
4 hours ago
INmune Bio undervalued as Ebstrocel for RDEB nears key regulatory milestones with $67M market cap.

INmune Bio undervalued as Ebstrocel for RDEB nears key regulatory milestones with $67M market cap.

INmune Bio is considered significantly undervalued with its treatment Ebstrocel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) driving a strong investment case. Ebstrocel offers systemic itch reduction, setting it apart from competitors like K...

Market News
Bullish
4 hours ago
PayPal stock plunges 14.67% after Stripe and Advent withdraw $60.50/share acquisition offer

PayPal stock plunges 14.67% after Stripe and Advent withdraw $60.50/share acquisition offer

PayPal's stock dropped sharply by 14.67% to $52.45 after Stripe and Advent withdrew their $60.50 per share acquisition offer, causing the company's market value to fall from $52.58 billion to $44.87 billion. This reversal ended the summer rally drive...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App